These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27806853)

  • 1. Cutaneous myeloid dendritic cell dyscrasia: A cutaneous clonal monocytosis associated with chronic myeloproliferative disorders and peripheral blood monocytosis.
    Magro CM; Momtahen S; Verma S; Abraham RM; Friedman C; Nuovo GJ; Tam W
    Ann Diagn Pathol; 2016 Dec; 25():85-91. PubMed ID: 27806853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histiocytoid Sweet's Syndrome: A localized cutaneous proliferation of macrophages frequently associated with chronic myeloproliferative disease.
    Magro CM; Momtahen S; Nguyen GH; Wang X
    Eur J Dermatol; 2015; 25(4):335-41. PubMed ID: 26067166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow.
    Sadigh S; DeAngelo DJ; Garcia JS; Hasserjian RP; Hergott CB; Lane AA; Lovitch SB; Lucas F; Luskin MR; Morgan EA; Pinkus GS; Pozdnyakova O; Rodig SJ; Shanmugam V; Tsai HK; Winer ES; Zemmour D; Kim AS
    Mod Pathol; 2024 Jan; 37(1):100352. PubMed ID: 37839675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD1c(+) myeloid dendritic cells in myeloid neoplasia.
    Meyerson HJ; Osei E; Schweitzer K; Blidaru G; Edinger A; Schlegelmilch J; Awadallah A; Goyal T
    Cytometry B Clin Cytom; 2016 Jul; 90(4):337-48. PubMed ID: 26502918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow leukaemic transformation of myelodysplastic syndrome revealed by a cutaneous Langerhans cell infiltrate: partial response to azacitidine.
    Osio A; Elfatoiki F; Raffoux E; Vignon-Pennamen MD; de Labarthe A; Cordoliani F; Petrella T; Bagot M; Janin A; Battistella M; Bouaziz JD
    Eur J Dermatol; 2013; 23(5):710-1. PubMed ID: 24125873
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemia.
    Loghavi S; Curry JL; Garcia-Manero G; Patel KP; Xu J; Khoury JD; Torres-Cabala CA; Nagarajan P; Aung PP; Gibson BR; Goodwin BP; Kelly BC; Korivi BR; Medeiros LJ; Prieto VG; Kantarjian HM; Bueso-Ramos CE; Tetzlaff MT
    J Cutan Pathol; 2017 Dec; 44(12):1075-1079. PubMed ID: 28885734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous extramedullary hemopoiesis in chronic myeloproliferative and myelodysplastic disorders.
    Haniffa MA; Wilkins BS; Blasdale C; Simpson NB
    J Am Acad Dermatol; 2006 Aug; 55(2 Suppl):S28-31. PubMed ID: 16843120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells in bone marrow at diagnosis and after chemotherapy in adult patients with acute myeloid leukaemia.
    Derolf AR; Laane E; Björklund E; Saft L; Björkholm M; Porwit A
    Scand J Immunol; 2014 Dec; 80(6):424-31. PubMed ID: 25346147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes/interferon-producing cells associated with myeloid disorders.
    Vermi W; Facchetti F; Rosati S; Vergoni F; Rossi E; Festa S; Remotti D; Grigolato P; Massarelli G; Frizzera G
    Am J Surg Pathol; 2004 May; 28(5):585-95. PubMed ID: 15105645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermal Langerhans' cell tumor in chronic myelomonocytic leukemia.
    Kaiserling E; Horny HP
    Ultrastruct Pathol; 1988; 12(2):209-19. PubMed ID: 3163210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
    Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V
    Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmacytoid Dendritic Cell Dermatosis Associated to Myeloproliferative/Myelodysplastic Neoplasms.
    Machan S; Alonso-Dominguez JM; Sánchez García FJ; Nieves Salgado R; Soto C; Castro Y; Pajares R; Manso R; Santonja C; Serrano Del Castillo C; Piris MA; Requena L; Rodríguez Pinilla SM
    Am J Surg Pathol; 2022 Dec; 46(12):1623-1632. PubMed ID: 36001453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophilic dermatoses and myeloproliferative disease: report of two cases.
    Gibson LE; Dicken CH; Flach DB
    Mayo Clin Proc; 1985 Nov; 60(11):735-40. PubMed ID: 3863998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quantitative analysis of dendritic cell subsets in bone marrow of patients with acute myeloid leukemia].
    Lin HR; Wang YZ; Wang DX; Chang Y; Hao L; Qin YZ; Li JL; Li LD; Huang XJ; Liu YR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1249-54. PubMed ID: 19840461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of lineage relationships and novel markers of blood and skin human dendritic cells.
    Harman AN; Bye CR; Nasr N; Sandgren KJ; Kim M; Mercier SK; Botting RA; Lewin SR; Cunningham AL; Cameron PU
    J Immunol; 2013 Jan; 190(1):66-79. PubMed ID: 23183897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonality in the setting of Sweet's syndrome and pyoderma gangrenosum is not limited to underlying myeloproliferative disease.
    Magro CM; Kiani B; Li J; Crowson AN
    J Cutan Pathol; 2007 Jul; 34(7):526-34. PubMed ID: 17576331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell depletion in burn patients is regulated by MafB expression.
    Williams KN; Szilagyi A; He LK; Conrad P; Halerz M; Gamelli RL; Shankar R; Muthumalaiappan K
    J Burn Care Res; 2012; 33(6):747-58. PubMed ID: 22868453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
    Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.
    Grabrucker C; Liepert A; Dreyig J; Kremser A; Kroell T; Freudenreich M; Schmid C; Schweiger C; Tischer J; Kolb HJ; Schmetzer H
    J Immunother; 2010 Jun; 33(5):523-37. PubMed ID: 20463595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.